Intestinal anti-inflammatory activity of luteolin: Role of the aglycone in NF-κB inactivation in macrophages co-cultured with intestinal epithelial cells

BioFactors

Volumn 39, Issue 5, 2013, Pages 522-533

  Nishitani, Yosuke ^a   Yamamoto, Koji ^b   Yoshida, Masaru ^b   Azuma, Takeshi ^b   Kanazawa, Kazuki ^a   Hashimoto, Takashi ^a   Mizuno, Masashi ^a  

^a KOBE UNIVERSITY   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti inflammatory; DSS induced colitis; Luteolin; TNF

Indexed keywords

AGLYCONE; BUDESONIDE; DEXTRAN SULFATE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; LUTEOLIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL STRAIN CACO 2; COCULTURE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTI-INFLAMMATORY; DSS-INDUCED COLITIS; LUTEOLIN; TNF-Α;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL NUCLEUS; COCULTURE TECHNIQUES; COLON; CYCLOOXYGENASE 2; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; IRRITABLE BOWEL SYNDROME; LUTEOLIN; MACROPHAGES; MICE; MICE, INBRED C57BL; NF-KAPPA B; PROTEIN TRANSPORT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84886437998     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1091     Document Type: Article

References (33)

1. Ley, R. E., Peterson, D. A., andGordon, J. I. (2006)Ecological and evolutionary forces shaping microbial diversity in the human intestine.Cell124, 837-848.
2. Denning, T. L., Wang, Y., Patel, S. R., Williams, I. R., andPulendran, B. (2007)Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses.Nat. Immunol.8, 1086-1094.
3. Arai, F., Takahashi, T., Furukawa, K., Matsushima, K., andAsakura, H. (1998)Mucosal expression of interleukin-6 and interleukin-8 messenger RNA in ulcerative colitis and Crohn's disease.Dig. Dis. Sci.43, 2071-2079.
4. Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., et al. (2008)Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis.J. Clin. Invest.118, 2269-2280.
5. Chin, A. C. andParkos, C. A. (2006)Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking.Ann. N. Y. Acad. Sci.1072, 276-287.
6. Zareie, M., Singh, P. K., Irvine, E. J., Sherman, P. M., McKay, D. M., et al. (2001)Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease.Am. J. Pathol.158, 1101-1109.
7. Struyf, S., Gouwy, M., Dillen, C., Proost, P., Opdenakker, G., et al. (2005)Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue.Eur. J. Immunol.35, 1583-1591.
8. Asakura, H., Suzuki, K., Honma, T. (2007)Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?World J. Gastroenterol.13, 2145-2149.
9. Manach, C., Scalbert, A., Morand, C., Rémésy, C., andJiménez, L. (2004)Polyphenols: food sources and bioavailability.Am. J. Clin. Nutr.79, 727-747.
10. Ross, J. A. andKasum, C. M. (2002)Dietary flavonoids: bioavailability, metabolic effects, and safety.Annu. Rev. Nutr.22:19-34.
11. Seelinger, G., Merfort, I., andSchempp, C. M. (2008)Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin.Planta Med.74, 1667-1677.
12. Ashokkumar, P. andSudhandiran, G. (2008)Protective role of luteolin on the status of lipid peroxidation and antioxidant defense against azoxymethane-induced experimental colon carcinogenesis.Biomed. Pharmacother.62, 590-597.
13. Hougee, S., Sanders, A., Faber, J., Graus, Y. M., van den Berg, W. B., et al. (2005)Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages.Biochem. Pharmacol.69, 241-248.
14. Kim, J. S. andJobin, C. (2005)The flavonoid luteolin prevents lipopolysaccharide induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells.Immunology115, 375-387.
15. Kotanidou, A., Xagorari, A., Bagli, E., Kitsanta, P., Fotsis, T., et al. (2002)Luteolin reduces lipopolysaccharide-induced lethal toxicity and expression of proinflammatory molecules in mice.Am. J. Respir. Crit. Care Med.165, 818-823.
16. Xagorari, A., Papapetropoulos, A., Mauromatis, A., Economou, M., Fotsis, T., et al. (2001)Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages.J. Pharmacol. Exp. Ther.296, 181-187.
17. Ziyan, L., Yongmei, Z., Nan, Z., Ning, T., andBaolin, L. (2007)Evaluation of the anti-inflammatory activity of luteolin in experimental animal models.Planta Med.73, 221-226.
18. Karrasch, T., Kim, J. S., Jang, B. I., andJobin, C. (2007)The flavonoid luteolin worsens chemical-induced colitis in NF-kappaB (EGFP) transgenic mice through blockade of NF-kappaB-dependent protective molecules.PLoS One2, e596.
19. Kim, J. A., Kim, D. K., Kang, O. H., Choi, Y. A., Park, H. J., et al. (2005)Inhibitory effect of luteolin on TNF-alpha-induced IL-8 production in human colon epithelial cells.Int. Immunopharmacol.5, 209-217.
20. Chen, C. Y., Peng, W. H., Tsai, K. D., andHsu, S. L. (2007)Luteolin suppresses inflammation-associated gene expression by blocking NF-kappaB and AP-1 activation pathway in mouse alveolar macrophages.Life Sci.81, 1602-1614.
21. Tanoue, T., Nishitani, Y., Kanazawa, K., Hashimoto, T., andMizuno, M. (2008)In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells.Biochem. Biophys. Res. Commun.374, 565-569.
22. Hudert, C. A., Weylandt, K. H., Lu, Y., Wang, J., Hong, S., et al. (2006)Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis.Proc. Natl. Acad. Sci. USA103, 11276-11281.
23. Takada, K., Ohno, N., andYadomae, T. (1994)Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo.Infect. Immun.62, 1171-1175.
24. Noursadeghi, M., Tsang, J., Haustein, T., Miller, R. F., Chain, B. M., et al. (2008)Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages.J. Immunol. Methods329, 194-200.
25. + T cells in the development of dextran sulfate sodium-induced experimental colitis and suppressive effect of IgG on their action.Gen. Pharmacol.31, 477-481.
26. Chan, E. P. andLichtenstein, G. R. (2006)Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.Gastroenterol. Clin. North. Am.35, 675-712.
27. Bettelli, E., Korn, T., Oukka, M., andKuchroo, V. K. (2008)Induction and effector functions of T(H)17 cells.Nature453, 1051-1057.
28. Hedl, M. andAbraham, C. (2011)Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.J. Biol. Chem.286, 26440-26449.
29. Bachmanov, A. A., Reed, D. R., Beauchamp, G. K., andTordoff, M. G. (2002)Food intake, water intake, and drinking spout side preference of 28 mouse strains.Behav. Genet.32, 435-443.
30. Kim, M., Murakami, A., Miyamoto, S., Tanaka, T., andOhigashi, H. (2010)The modifying effects of green tea polyphenols on acute colitis and inflammation-associated colon carcinogenesis in male ICR mice.Biofactors36, 43-51.
31. Ung, V. Y., Foshaug, R. R., MacFarlane, S. M., Churchill, T. A., Doyle, J. S., et al. (2010)Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.Dig. Dis. Sci.55, 1272-1277.
32. Brown, K. D., Claudio, E., andSiebenlist, U. (2008)The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis.Arthritis Res. Ther.10, 212.
33. Murota, K., Shimizu, S., Miyamoto, S., Izumi, T., Obata, A., et al. (2002)Unique uptake and transport of isoflavone aglycones by human intestinal Caco-2 cells: comparison of isoflavonoids and flavonoids.J. Nutr.132, 1956-1961.